ResMed, Inc. (RMD)
224.72
-4.08
(-1.78%)
USD |
NYSE |
Apr 16, 16:00
224.78
+0.06
(+0.03%)
Pre-Market: 20:00
ResMed Research and Development Expense (Quarterly) : 90.97M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 569.00M |
| Baxter International, Inc. | 116.00M |
| Abbott Laboratories | 721.00M |
| Globus Medical, Inc. | 36.16M |
| Intuitive Surgical, Inc. | 352.90M |